Skip to Content
Morningstar

BlackRock US Carbon Transition Rdnss ETF LCTU

Morningstar Medalist Rating
Medalist Rating as of | See BlackRock Investment Hub

Morningstar’s Analysis LCTU

Will LCTU outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable LCTU’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the LCTU management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of LCTU’s parent organization’s priorities and whether they’re in line with investors’ interests.

BlackRock US Carbon Transition Rdnss ETF’s management team is rated Average, but a solid investment process still helps this strategy retain its Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the lowest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LCTU

More LCTU Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 30.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Apple Inc

5.82 68.6 Mil
Technology

Microsoft Corp

5.56 65.5 Mil
Technology

NVIDIA Corp

3.97 46.8 Mil
Technology

Amazon.com Inc

3.41 40.1 Mil
Consumer Cyclical

Meta Platforms Inc Class A

2.37 27.9 Mil
Communication Services

Alphabet Inc Class A

2.17 25.6 Mil
Communication Services

Mastercard Inc Class A

1.81 21.3 Mil
Financial Services

Alphabet Inc Class C

1.77 20.9 Mil
Communication Services

Johnson & Johnson

1.71 20.2 Mil
Healthcare

Eli Lilly and Co

1.56 18.4 Mil
Healthcare